In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
- PMID: 36442812
- PMCID: PMC9868680
- DOI: 10.1016/j.jcmgh.2022.11.008
In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
Abstract
In vitro models of liver (patho)physiology, new technologies, and experimental approaches are progressing rapidly. Based on cell lines, induced pluripotent stem cells or primary cells derived from mouse or human liver as well as whole tissue (slices), such in vitro single- and multicellular models, including complex microfluidic organ-on-a-chip systems, provide tools to functionally understand mechanisms of liver health and disease. The International Society of Hepatic Sinusoidal Research (ISHSR) commissioned this working group to review the currently available in vitro liver models and describe the advantages and disadvantages of each in the context of evaluating their use for the study of liver functionality, disease modeling, therapeutic discovery, and clinical applicability.
Keywords: Bioengineering; Cirrhosis; Hepatic Sinusoid; Mechanobiology; NAFLD; NASH; Omics.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Figures



Similar articles
-
In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications.iScience. 2021 Dec 4;25(1):103549. doi: 10.1016/j.isci.2021.103549. eCollection 2022 Jan 21. iScience. 2021. PMID: 34977507 Free PMC article. Review.
-
From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease.Biochem Pharmacol. 2020 Oct;180:114173. doi: 10.1016/j.bcp.2020.114173. Epub 2020 Jul 25. Biochem Pharmacol. 2020. PMID: 32717228 Review.
-
Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations.Cell Mol Gastroenterol Hepatol. 2023;15(5):1135-1145. doi: 10.1016/j.jcmgh.2023.01.014. Epub 2023 Feb 3. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36740045 Free PMC article. Review.
-
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device.PLoS One. 2016 Jul 20;11(7):e0159729. doi: 10.1371/journal.pone.0159729. eCollection 2016. PLoS One. 2016. PMID: 27438262 Free PMC article.
-
Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models.Antioxidants (Basel). 2021 Dec 30;11(1):86. doi: 10.3390/antiox11010086. Antioxidants (Basel). 2021. PMID: 35052590 Free PMC article. Review.
Cited by
-
NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models.Cancers (Basel). 2023 Jul 22;15(14):3723. doi: 10.3390/cancers15143723. Cancers (Basel). 2023. PMID: 37509384 Free PMC article. Review.
-
Bridging the gap: From petri dish to patient - Advancements in translational drug discovery.Heliyon. 2024 Dec 17;11(1):e41317. doi: 10.1016/j.heliyon.2024.e41317. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39811269 Free PMC article. Review.
-
Mechanobiology of portal hypertension.JHEP Rep. 2023 Aug 2;5(11):100869. doi: 10.1016/j.jhepr.2023.100869. eCollection 2023 Nov. JHEP Rep. 2023. PMID: 37841641 Free PMC article. Review.
-
How to Establish a Novel Liver Cell Culture System That Resembles the In Vivo Liver Microenvironment.Curr Protoc. 2025 Jul;5(7):e70172. doi: 10.1002/cpz1.70172. Curr Protoc. 2025. PMID: 40650428 Free PMC article.
-
Global hotspots and emerging trends in 3D bioprinting research.Front Bioeng Biotechnol. 2023 May 25;11:1169893. doi: 10.3389/fbioe.2023.1169893. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37304138 Free PMC article.
References
-
- Karlsen T.H., Sheron N., Zelber-Sagi S., et al. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2022;399:61–116. - PubMed
-
- Nevzorova Y.A., Boyer-Diaz Z., Cubero F.J., Gracia-Sancho J. Animal models for liver disease – a practical approach for translational research. J Hepatol. 2020;73:423–440. - PubMed
-
- Polidoro M.A., Ferrari E., Marzorati S., et al. Experimental liver models: from cell culture techniques to microfluidic organs-on-chip. Liver Int. 2021;41:1744–1761. - PubMed
-
- Ortega-Ribera M., Yeste J., Villa R., Gracia-Sancho J. In: Nanoengineered biomaterials for regenerative medicine. Mozafari M., Rajadas J., Kaplan D., editors. Elsevier; 2018. Nanoengineered biomaterials for the treatment of liver diseases; pp. 417–441.